Medicaid Coverage of and Spending on GLP-1s November 4, 2024 Issue Brief This brief examines the implications of rising prescriptions for costly GLP-1 drugs for state Medicaid programs as more states consider covering the drugs for weight loss. It examines recent trends in Medicaid prescriptions and gross spending on GLP-1s, and explores the potential implications of expanding coverage obesity drugs for Medicaid programs.
States With an Intermediate Care Facility for Those With Intellectual Disabilities (ICF-IDs) Provider Tax in Place November 1, 2024 State Indicator
States Reporting Social Determinant of Health Related Policies Required in Medicaid Managed Care Contracts November 1, 2024 State Indicator
